Sebastiaan SA
1.6 FTESebastiaan reported total assets of €2.61m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 1.6 full-time equivalent.
The score of Sebastiaan shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +22 % Total assets -3 % Headcount (avg FTE) -33 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sebastiaan's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 19 Sep 2024
- Year ended 31 Dec 2022filed on 07 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Sebastiaan's financial analysis
- Solvency44.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sebastiaan
Sebastiaan's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.096.340
- VAT number
- BE0449096340
- Peppol
- Registered · 0208:0449096340 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 11 Jan 1993
- Registered office
- 1630 Linkebeek
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sebastiaan (SA) has been based in Linkebeek since 1993, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 54,601 € and equity of €1.16m; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 44.6%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sebastiaan
Companies in the same business, of comparable size and area, outside its group.
- Elbaro Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €2.78m
- Pharmacie DEMOULIN-CLAISSE Retail sale of pharmaceutical products Arlon · balance sheet €2.61m
- Apotheek Peeters - Petit Retail sale of pharmaceutical products Maasmechelen · balance sheet €5.05m
- Paliseul Pharma Retail sale of pharmaceutical products Paliseul · balance sheet €2.63m
- Delfosse Marie Retail sale of pharmaceutical products Tournai · balance sheet €2.65m
- Ollo Pharma Retail sale of pharmaceutical products Marche-en-Famenne · balance sheet €2.66m
- Philippe Sollie Retail sale of pharmaceutical products Zoersel · balance sheet €2.69m
- Deligne Retail sale of pharmaceutical products Ath · balance sheet €2.71m
Frequently asked questions about Sebastiaan
What is the revenue of Sebastiaan?
Sebastiaan files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sebastiaan?
In Belgium, the VAT number is the company number prefixed with BE: BE0449096340 for Sebastiaan, if the company is VAT-registered. Its company number (CBE) is 0449.096.340.
Where is the registered office of Sebastiaan?
According to the CBE register, the registered office of Sebastiaan is in 1630 Linkebeek.
What is the equity of Sebastiaan?
At the close of the 2025 financial year, the equity of Sebastiaan amounts to 1,163,424 €, a solvency of 44.6% of total assets.
How many people work at Sebastiaan?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sebastiaan?
The register lists 4 active mandates at Sebastiaan. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sebastiaan
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →